Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

318.78
Delayed Data
As of Jul 31
 +1.78 / +0.56%
Today’s Change
290.85
Today|||52-Week Range
480.18
-6.09%
Year-to-Date

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for Biogen have a median target of 400.00, with a high estimate of 494.00 and a low estimate of 291.00. The median estimate represents a +25.48% increase from the last price of 318.78.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Biogen. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.92
Sales
$2.7B
Reporting Date
Oct 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.12%
 
 
 
 
 
 
Growthannually 15.17%
 
 
 
 
 
 

Sales

Growthquarterly 2.35%
 
 
 
 
 
 
Growthannually 8.44%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.